Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction

Author： Coons James C Schwier Nicholas Harris Justin Seybert Amy L

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.4, 2014-04, pp. : 609-620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction

By Darbà J.

PharmacoEconomics, Vol. 20, Iss. 3, 2002-01 ,pp. : 195-201

Adis International

Access to resources Recommend Favorite

Importance of potent P2Y₁₂ receptor blockade in acute myocardial infarction: focus on prasugrel

By Jeong Young-Hoon Tantry Udaya S Gurbel Paul A

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1771-1796

Informa Healthcare

Access to resources Recommend Favorite

The effects of hyperoxic ventilation in the treatment of myocardial infarction

By CONTI C. RICHARD

Transfusion Alternatives in Transfusion Medicine, Vol. 11, Iss. 4, 2010-12 ,pp. : 143-147

Blackwell Publishing

Access to resources Recommend Favorite

Stem Cell Therapy for the Treatment of Myocardial Infarction

Current Pharmaceutical Design, Vol. 17, Iss. 30, 2011-10 ,pp. : 3328-3340

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis

By Gatti Davide

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 883-892

Informa Healthcare

Access to resources Recommend Favorite